Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT00676494
Eligibility Criteria:
Inclusion Criteria:
* Documented symptomatic atherosclerotic peripheral vascular disease
* Target lesion(s) is/are located in a superficial femoral, popliteal and/or infrapopliteal arteries
* The patient has been informed of the nature of the study and has provided informed consent
* The patient agrees and has capability to meet study requirements and be present at the follow-up clinic visits
Exclusion Criteria:
* Target lesion is located in the iliac artery.
* Target lesion stenosis is \< 70%.
* Interventional treatment is intended for in-stent restenosis at the peripheral vascular site.
* Patient is unable to participate for the duration of the study.
* Patient is currently participating or has participated in a study with another investigational medical device or medication.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00676494
Study Brief:
Protocol Section:
NCT00676494